41768 - NHS: Drugs (Answered)

Mr Nicholas Brown
To ask the Secretary of State for Health, what recent progress has been made on the Competition Market Authority's investigation into claims that generic drug procurement costs are being artificially increased by suppliers.

George Freeman

41736 - Cancer (Answered)

David Tredinnick
To ask the Secretary of State for Health, if he will take steps to review the decision to remove peptide receptor radionuclide therapy treatments from the Cancer Drugs Fund list.

George Freeman

The National Institute for Health and Care Excellence (NICE) is currently appraising the peptide receptor radionuclide therapy treatment lutetium-177-DOTA octreotate for the treatment of neuroendocrine tumours and for gastroenteropancreatic neuroendocrine tumours.

41881 - Andrew Gwynne - 05-Jul-2016 (Answered)

Andrew Gwynne
To ask the Secretary of State for Health, if he will direct Public Health England to commission research into the inequality of the distribution of sexually transmitted infections between young people and the rest of the population.

George Freeman

41780 - Neuromuscular Disorders (Answered)

Danny Kinahan
To ask the Secretary of State for Health, if he will take steps to ensure that UK access to emerging treatments for (a) muscular dystrophy and (b) other neuromuscular conditions is maintained in the event of the UK leaving the EU.

George Freeman

41826 - Headaches (Answered)

Jim Shannon
To ask the Secretary of State for Health, whether the Government plans for TEV-48125 to be made available on the NHS.

George Freeman

TEV-48125 is still undergoing clinical trials in the United States for the treatment of migraine and it would be premature to comment on its future availability on the National Health Service.

42042 - Hospitals: Waiting Lists (Answered)

Mr Jim Cunningham
To ask the Secretary of State for Health, what assessment he has made of the potential effect of NHS efficiency savings on waiting times in each of the next five years; and if he will make a statement.

George Freeman

41629 - Respiratory Syncytial Virus: Babies (Answered)

Sir David Amess
To ask the Secretary of State for Health, pursuant to the Answer of 22 January 2016 to Question 22462, if he will place in the Library a copy of NHS England's report on individual funding requests for palivizumab.

George Freeman

I refer the hon. Member to the Answer I gave to the hon. Member for Ealing, Southall (Mr Virendra Sharma) on 28 June 2016 to Question 40748.

41456 - Antibiotics (Answered)

Daniel Zeichner
To ask the Secretary of State for Health, what discussions Ministers of his Department have had with their counterparts in the devolved administrations on development of new antibiotics and encouraging innovation in such development through reform of evaluation and reimbursement mechanisms.

George Freeman

41572 - Medical Treatments (Answered)

Daniel Zeichner
To ask the Secretary of State for Business, Innovation and Skills, what engagement his Department has had with the Accelerated Access Review (AAR); and whether the AAR plans to investigate expediting the delivery of new drugs and devices to tackle MRSA and antimicrobial resistance.

George Freeman

41473 - Health Services (Answered)

Dr Sarah Wollaston
To ask the Secretary of State for Health, whether NHS England has met the key deliverable in the 2014-15 NHS England business plan to ensure that more than 70 per cent of all scientific and diagnostic services are part of accreditation programmes.

George Freeman

Pages